<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1232"/><api:result><api:object category="publication" id="1232" last-affected-when="2024-04-14T07:09:39.26+01:00" last-modified-when="2024-04-14T07:09:39.26+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1232" created-when="2010-05-17T13:47:34.057+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2000-01-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1409528" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1016/S0959-8049(00)00159-3" last-modified-when="2023-04-10T23:11:49.937+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0959-8049(00)00159-3</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0959-8049(00)00159-3"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0959-8049(00)00159-3"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0959-8049</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973854"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>13</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>European Journal of Cancer</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1649</api:begin-page><api:end-page>1660</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier BV</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1016/s0959-8049(00)00159-3</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>9</api:day><api:month>4</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>36</api:text></api:field></api:native></api:record><api:record format="native" id="95661" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0033867776" last-modified-when="2023-08-02T05:59:22.793+01:00"><api:citation-count>259</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Tumour hypoxia is the result of an imbalance in oxygen supply and demand. It is an adverse prognostic indicator in cancer as it modulates tumour progression and treatment. Many genes controlling tumour biology are oxygen regulated, and new ones are constantly added to the growing list of hypoxia-induced genes. Of specific importance are hypoxia-responsive transcription factors, as they can modulate the expression of numerous different genes. Similarly, growth factors which govern the formation of new blood vessels or which control blood flow are vitally important for both the maintenance of the primary tumour and metastases at distant sites. The purpose of this review is to present an update of selected issues regarding hypoxia-inducible gene expression and how this affects prognosis, angiogenesis and metastasis. It will conclude by discussing gene therapy as one possible means of exploiting tumour hypoxia for the treatment of cancer. Â© 2000 Elsevier Science Ltd.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Mount Vernon Hospital</api:line><api:line type="city">Northwood</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6701404593</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Mount Vernon Hospital</api:line><api:line type="city">Northwood</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005831992</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/S0959-8049(00)00159-3</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/S0959-8049(00)00159-3"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/S0959-8049(00)00159-3"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10959051</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0959-8049</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973854"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>13</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>European Journal of Cancer</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1649</api:begin-page><api:end-page>1660</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Hypoxia modulated gene expression: Angiogenesis, metastasis and therapeutic exploitation</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>36</api:text></api:field></api:native></api:record><api:record format="native" id="1232" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10959051" last-modified-when="2020-04-29T01:20:09.447+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Tumour hypoxia is the result of an imbalance in oxygen supply and demand. It is an adverse prognostic indicator in cancer as it modulates tumour progression and treatment. Many genes controlling tumour biology are oxygen regulated, and new ones are constantly added to the growing list of hypoxia-induced genes. Of specific importance are hypoxia-responsive transcription factors, as they can modulate the expression of numerous different genes. Similarly, growth factors which govern the formation of new blood vessels or which control blood flow are vitally important for both the maintenance of the primary tumour and metastases at distant sites. The purpose of this review is to present an update of selected issues regarding hypoxia-inducible gene expression and how this affects prognosis, angiogenesis and metastasis. It will conclude by discussing gene therapy as one possible means of exploiting tumour hypoxia for the treatment of cancer.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Tumour Microcirculation Group, Gray Laboratory Cancer Research Trust, PO Box 100, Mount Vernon Hospital, HA6 2JR, Northwood, UK.</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10959051</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0959-8049(00)00159-3</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0959-8049(00)00159-3"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0959-8049(00)00159-3"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0959-8049</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973854"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>13 Spec No</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Eur J Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Cell Hypoxia</api:keyword><api:keyword scheme="mesh">DNA-Binding Proteins</api:keyword><api:keyword scheme="mesh">Endothelial Growth Factors</api:keyword><api:keyword scheme="mesh">Genes, p53</api:keyword><api:keyword scheme="mesh">Genetic Therapy</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Hypoxia-Inducible Factor 1</api:keyword><api:keyword scheme="mesh">Hypoxia-Inducible Factor 1, alpha Subunit</api:keyword><api:keyword scheme="mesh">Lymphokines</api:keyword><api:keyword scheme="mesh">Matrix Metalloproteinases</api:keyword><api:keyword scheme="mesh">Neoplasm Metastasis</api:keyword><api:keyword scheme="mesh">Neoplasm Proteins</api:keyword><api:keyword scheme="mesh">Neoplasms</api:keyword><api:keyword scheme="mesh">Neovascularization, Pathologic</api:keyword><api:keyword scheme="mesh">Nitric Oxide Synthase</api:keyword><api:keyword scheme="mesh">Nuclear Proteins</api:keyword><api:keyword scheme="mesh">Transcription Factors</api:keyword><api:keyword scheme="mesh">Urokinase-Type Plasminogen Activator</api:keyword><api:keyword scheme="mesh">Vascular Endothelial Growth Factor A</api:keyword><api:keyword scheme="mesh">Vascular Endothelial Growth Factors</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1649</api:begin-page><api:end-page>1660</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0959-8049(00)00159-3</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>7</api:day><api:month>11</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>36</api:text></api:field></api:native></api:record><api:record format="native" id="882324" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10959051" last-modified-when="2023-09-12T18:38:46.213+01:00"><api:citation-count>138</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Tumour hypoxia is the result of an imbalance in oxygen supply and demand. It is an adverse prognostic indicator in cancer as it modulates tumour progression and treatment. Many genes controlling tumour biology are oxygen regulated, and new ones are constantly added to the growing list of hypoxia-induced genes. Of specific importance are hypoxia-responsive transcription factors, as they can modulate the expression of numerous different genes. Similarly, growth factors which govern the formation of new blood vessels or which control blood flow are vitally important for both the maintenance of the primary tumour and metastases at distant sites. The purpose of this review is to present an update of selected issues regarding hypoxia-inducible gene expression and how this affects prognosis, angiogenesis and metastasis. It will conclude by discussing gene therapy as one possible means of exploiting tumour hypoxia for the treatment of cancer.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Tumour Microcirculation Group, Gray Laboratory Cancer Research Trust, PO Box 100, Mount Vernon Hospital, HA6 2JR, Northwood, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0959-8049(00)00159-3</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0959-8049(00)00159-3"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0959-8049(00)00159-3"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1879-0852</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973854"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10959051</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0959-8049</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973854"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>13 Spec No</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>European journal of cancer (Oxford, England : 1990)</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Neoplasms</api:keyword><api:keyword scheme="mesh">Neoplasm Metastasis</api:keyword><api:keyword scheme="mesh">Neovascularization, Pathologic</api:keyword><api:keyword scheme="mesh">Matrix Metalloproteinases</api:keyword><api:keyword scheme="mesh">Vascular Endothelial Growth Factors</api:keyword><api:keyword scheme="mesh">Vascular Endothelial Growth Factor A</api:keyword><api:keyword scheme="mesh">Endothelial Growth Factors</api:keyword><api:keyword scheme="mesh">DNA-Binding Proteins</api:keyword><api:keyword scheme="mesh">Neoplasm Proteins</api:keyword><api:keyword scheme="mesh">Nuclear Proteins</api:keyword><api:keyword scheme="mesh">Transcription Factors</api:keyword><api:keyword scheme="mesh">Lymphokines</api:keyword><api:keyword scheme="mesh">Cell Hypoxia</api:keyword><api:keyword scheme="mesh">Genes, p53</api:keyword><api:keyword scheme="mesh">Nitric Oxide Synthase</api:keyword><api:keyword scheme="mesh">Hypoxia-Inducible Factor 1</api:keyword><api:keyword scheme="mesh">Hypoxia-Inducible Factor 1, alpha Subunit</api:keyword><api:keyword scheme="mesh">Urokinase-Type Plasminogen Activator</api:keyword><api:keyword scheme="mesh">Genetic Therapy</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1649</api:begin-page><api:end-page>1660</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>26</api:day><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Review</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>36</api:text></api:field></api:native></api:record><api:record format="native" id="2903634" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1021713439" last-modified-when="2024-04-14T07:09:39.263+01:00"><api:citation-count>223</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>3</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0731561243.29</api:identifier></api:identifiers><api:author-types><api:author-type>corresponding</api:author-type></api:author-types></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0736063251.63</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0959-8049(00)00159-3</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0959-8049(00)00159-3"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0959-8049(00)00159-3"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10959051</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>23.27</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0959-8049</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973854"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>13</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>European Journal of Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc">Genetics</api:keyword><api:keyword scheme="rcdc">Cancer</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="hrcs-hc">Cancer</api:keyword><api:keyword scheme="mesh">Cell Hypoxia</api:keyword><api:keyword scheme="mesh">DNA-Binding Proteins</api:keyword><api:keyword scheme="mesh">Endothelial Growth Factors</api:keyword><api:keyword scheme="mesh">Genes, p53</api:keyword><api:keyword scheme="mesh">Genetic Therapy</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Hypoxia-Inducible Factor 1</api:keyword><api:keyword scheme="mesh">Hypoxia-Inducible Factor 1, alpha Subunit</api:keyword><api:keyword scheme="mesh">Lymphokines</api:keyword><api:keyword scheme="mesh">Matrix Metalloproteinases</api:keyword><api:keyword scheme="mesh">Neoplasm Metastasis</api:keyword><api:keyword scheme="mesh">Neoplasm Proteins</api:keyword><api:keyword scheme="mesh">Neoplasms</api:keyword><api:keyword scheme="mesh">Neovascularization, Pathologic</api:keyword><api:keyword scheme="mesh">Nitric Oxide Synthase</api:keyword><api:keyword scheme="mesh">Nuclear Proteins</api:keyword><api:keyword scheme="mesh">Transcription Factors</api:keyword><api:keyword scheme="mesh">Urokinase-Type Plasminogen Activator</api:keyword><api:keyword scheme="mesh">Vascular Endothelial Growth Factor A</api:keyword><api:keyword scheme="mesh">Vascular Endothelial Growth Factors</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1649</api:begin-page><api:end-page>1660</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>4.48</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>36</api:text></api:field></api:native></api:record><api:record format="native" id="242160" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000089147400007" last-modified-when="2024-04-10T20:32:54.79+01:00"><api:citation-count>230</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000089147400007&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/S0959-8049(00)00159-3</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/S0959-8049(00)00159-3"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/S0959-8049(00)00159-3"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1879-0852</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973854"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">351FP</api:identifier><api:identifier scheme="pubmed">10959051</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0959-8049</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973854"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>13</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>EUROPEAN JOURNAL OF CANCER</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>hypoxia inducible factor-1</api:keyword><api:keyword>vascular endothelial growth factor</api:keyword><api:keyword>nitric oxide synthase</api:keyword><api:keyword>gene therapy</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1649</api:begin-page><api:end-page>1660</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>36</api:text></api:field></api:native></api:record><api:record format="native" id="25350" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000089147400007" last-modified-when="2014-07-25T11:08:17.213+01:00"><api:citation-count>147</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Dachs</api:last-name><api:initials>GU</api:initials><api:first-names>GU</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>U</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="434" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/434"/></api:links><api:last-name>Tozer</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0959-8049</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973854"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>13</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>EUR J CANCER</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>hypoxia inducible factor-1</api:keyword><api:keyword>vascular endothelial growth factor</api:keyword><api:keyword>nitric oxide synthase</api:keyword><api:keyword>gene therapy</api:keyword><api:keyword>ENDOTHELIAL GROWTH-FACTOR</api:keyword><api:keyword>NITRIC-OXIDE-SYNTHASE</api:keyword><api:keyword>FACTOR MESSENGER-RNA</api:keyword><api:keyword>INDUCIBLE FACTOR-I</api:keyword><api:keyword>FACTOR THYMIDINE PHOSPHORYLASE</api:keyword><api:keyword>UBIQUITIN-PROTEASOME PATHWAY</api:keyword><api:keyword>INTERNAL RIBOSOME ENTRY</api:keyword><api:keyword>ARGININE METHYL-ESTER</api:keyword><api:keyword>MURINE TUMOR-CELLS</api:keyword><api:keyword>TRANSCRIPTION FACTOR</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1649</api:begin-page><api:end-page>1660</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>36</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cell Hypoxia</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">DNA-Binding Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Endothelial Growth Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Genes, p53</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Genetic Therapy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Hypoxia-Inducible Factor 1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Hypoxia-Inducible Factor 1, alpha Subunit</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Lymphokines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Matrix Metalloproteinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Neoplasm Metastasis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Neoplasm Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Neovascularization, Pathologic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Nitric Oxide Synthase</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Nuclear Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Transcription Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Urokinase-Type Plasminogen Activator</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Vascular Endothelial Growth Factor A</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Vascular Endothelial Growth Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Neoplasm Metastasis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Neovascularization, Pathologic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Matrix Metalloproteinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Vascular Endothelial Growth Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Vascular Endothelial Growth Factor A</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Endothelial Growth Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">DNA-Binding Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Neoplasm Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Nuclear Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Transcription Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Lymphokines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cell Hypoxia</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Genes, p53</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Nitric Oxide Synthase</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Hypoxia-Inducible Factor 1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Hypoxia-Inducible Factor 1, alpha Subunit</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Urokinase-Type Plasminogen Activator</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Genetic Therapy</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Genetics</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cell Hypoxia</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">DNA-Binding Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Endothelial Growth Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Genes, p53</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Genetic Therapy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Hypoxia-Inducible Factor 1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Hypoxia-Inducible Factor 1, alpha Subunit</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Lymphokines</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Matrix Metalloproteinases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Neoplasm Metastasis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Neoplasm Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Neovascularization, Pathologic</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Nitric Oxide Synthase</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Nuclear Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Transcription Factors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Urokinase-Type Plasminogen Activator</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Vascular Endothelial Growth Factor A</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Vascular Endothelial Growth Factors</api:keyword><api:keyword origin="record-data" source="wos-lite">hypoxia inducible factor-1</api:keyword><api:keyword origin="record-data" source="wos-lite">vascular endothelial growth factor</api:keyword><api:keyword origin="record-data" source="wos-lite">nitric oxide synthase</api:keyword><api:keyword origin="record-data" source="wos-lite">gene therapy</api:keyword><api:keyword origin="record-data" source="wos">hypoxia inducible factor-1</api:keyword><api:keyword origin="record-data" source="wos">vascular endothelial growth factor</api:keyword><api:keyword origin="record-data" source="wos">nitric oxide synthase</api:keyword><api:keyword origin="record-data" source="wos">gene therapy</api:keyword><api:keyword origin="record-data" source="wos">ENDOTHELIAL GROWTH-FACTOR</api:keyword><api:keyword origin="record-data" source="wos">NITRIC-OXIDE-SYNTHASE</api:keyword><api:keyword origin="record-data" source="wos">FACTOR MESSENGER-RNA</api:keyword><api:keyword origin="record-data" source="wos">INDUCIBLE FACTOR-I</api:keyword><api:keyword origin="record-data" source="wos">FACTOR THYMIDINE PHOSPHORYLASE</api:keyword><api:keyword origin="record-data" source="wos">UBIQUITIN-PROTEASOME PATHWAY</api:keyword><api:keyword origin="record-data" source="wos">INTERNAL RIBOSOME ENTRY</api:keyword><api:keyword origin="record-data" source="wos">ARGININE METHYL-ESTER</api:keyword><api:keyword origin="record-data" source="wos">MURINE TUMOR-CELLS</api:keyword><api:keyword origin="record-data" source="wos">TRANSCRIPTION FACTOR</api:keyword><api:keyword scheme="for" origin="issn-inferred">1112 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="for" origin="issn-inferred">1117 Public Health and Health Services</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Oncology &amp; Carcinogenesis</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3211 Oncology and carcinogenesis</api:keyword></api:keywords></api:all-labels><api:journal issn="0959-8049" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973854" title="European Journal of Cancer"><api:records><api:record source-name="summary"><api:title>European Journal of Cancer</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1232/relationships"/></api:object></api:result></api:response>